BioSig Technologies, Inc.

NasdaqCM:BSGM Stock Report

Market Cap: US$25.0m

BioSig Technologies Management

Management criteria checks 0/4

BioSig Technologies' CEO is Anthony Amato, appointed in Apr 2024, has a tenure of less than a year. directly owns 4.83% of the company’s shares, worth $1.21M. The average tenure of the management team and the board of directors is 0.8 years and 1.8 years respectively.

Key information

Anthony Amato

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership4.8%
Management average tenureless than a year
Board average tenure1.8yrs

Recent management updates

Shareholders May Be More Conservative With BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Compensation For Now

Dec 12
Shareholders May Be More Conservative With BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Compensation For Now

Recent updates

Shareholders May Be More Conservative With BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Compensation For Now

Dec 12
Shareholders May Be More Conservative With BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Compensation For Now

Shareholders May Not Be So Generous With BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Compensation And Here's Why

Dec 14
Shareholders May Not Be So Generous With BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Compensation And Here's Why

BioSig in acquisition pact with San Antonio Hospital for cardiac signal system

Oct 07

BioSig: No Changes To Hold Thesis Following Q2 Earnings

Sep 08

BioSig signs purchase deal with Kansas City's Overland Park Regional hospital

Jul 07

BioSig: PURE EP Economics Trade Exhausted

Jun 14

CEO

Anthony Amato (55 yo)

less than a year

Tenure

Mr. Anthony Amato served as Member of Advisory Board at BioSig Technologies, Inc. from January 2021 to February 2024 and serves as its CEO & Chairman since April 30, 2024. He has corporate expertise in the...


Leadership Team

NamePositionTenureCompensationOwnership
Anthony Amato
CEO & Chairmanless than a yearno data4.83%
$ 1.2m
Ferdinand Groenewald
Interim CFO & Principal Accounting Officerless than a yearno datano data
Budimir Drakulic
Chief Scientist15.9yrsUS$243.75kno data
Lora Mikolaitis
Chief Administrative Officerno dataUS$147.00kno data

0.8yrs

Average Tenure

53yo

Average Age

Experienced Management: BSGM's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Anthony Amato
CEO & Chairmanless than a yearno data4.83%
$ 1.2m
Zachariah Zachariah
Member of Advisory Board4.8yrsno datano data
Lorraine Spurge
Member of Advisory Board1.8yrsno datano data
Edwin Wang
Member of Advisory Board1.8yrsno datano data
Frederick Hrkac
Directorless than a yearUS$701.58k3.8%
$ 949.0k
Sim Farar
Member of Advisory Board6.7yrsno datano data
Ramachandra Malya
Member of Advisory Board6.8yrsno datano data
Frank Quintero
Member of Advisory Board5.8yrsno datano data
Christopher Baer
Independent Directorless than a yearno data0.46%
$ 116.0k
Steven Abelman
Independent Directorless than a yearno data0.46%
$ 116.0k
Donald Browne
Independent Directorless than a yearno data0.46%
$ 116.0k

1.8yrs

Average Tenure

61.5yo

Average Age

Experienced Board: BSGM's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/07 01:49
End of Day Share Price 2025/01/07 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BioSig Technologies, Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC
Scott HenryRoth MKM